Alectos Therapeutics
PrivateLast Round
Strategic
Jun 6, 2022
Total Funding Raised
$15M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Alectos Therapeutics is a biotechnology company that discovers and develops novel small-molecule therapeutics for neurodegenerative and acute neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alectos Therapeutics Comparables
Compare Alectos Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Asceneuron | 87% | |
| Gain Therapeutics Inc | 77% | |
| Vanqua Bio | 76% | |
Alectos Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jun 6, 2022 | ||||
| Strategic | Aug 11, 2010 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors grew 770% MoM to 2.4K.
- Jul 21, 2025
Grew 23% QoQ, from 13 to 16 employees.
Alectos Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Alectos Therapeutics's valuation, stock price, and market status.